Multiple myeloma: open trials in Ireland

8 open trials have a site in Ireland. Registry data; only the trial team decides who can take part.

NCT05519085
A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)
Trial Treatment · Phase 3 · Celgene
Cork · Dublin · Galway · Limerick
Registry updated 2026-10-30
NCT05243797
Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation
Trial Treatment · Phase 3 · European Myeloma Network B.V.
Cork University Hospital, Cork · St Vincent's University Hospital, Dublin 4 · St James's Hospital, Dublin 8 · Beaumont Hospital, Dublin 9 · University Hospital Galway, Galway · University Hospital Limerick, Limerick · Sligo University Hospital, Sligo
Registry updated 2026-10-07
NCT06285318
A Study of Clinical Outcomes in Patients With Relapsed/Refractory Multiple Myeloma (RRMM) Treated With T-cell Redirectors Outside of Clinical Trials
Research · Janssen-Cilag Ltd.
Bon Secours Hospital, Cork · Cork University Hospital, Cork · St James Hospital, Dublin · Beacon Hospital, Dublin · University Hospital Galway - Ireland, Galway
Registry updated 2026-08-28
NCT06140524
A Proof-of-Concept Study to Learn Whether Linvoseltamab Can Eliminate Abnormal Plasma Cells That May Lead to Multiple Myeloma in Adult Patients With High-Risk Monoclonal Gammopathy of Undetermined Significance or Non-High-Risk Smoldering Multiple Myeloma
Trial Treatment · Phase 2 · Regeneron Pharmaceuticals
Cork University Hospital, Cork · Mater Misericordiae University Hospital, Dublin 7 · University Hospital Galway, Galway
Registry updated 2026-07-08
NCT06679101
A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)
Trial Treatment · Phase 3 · GlaxoSmithKline
Beaumont Hospital, Dublin 9 · University Hospital Galway, Galway · University Hospital Waterford, Waterford
Registry updated 2026-04-22
NCT06932562
A Study to Learn How Safe and How Well Linvoseltamab Works Compared to Standard Treatment in Adult Patients With Multiple Myeloma Who Are Not Eligible for Transplant
Trial Treatment · Phase 3 · European Myeloma Network B.V.
Cork University Hospital, Cork · Beaumont Hospital, Dublin 9 · University Hospital Galway, Galway · University Hospital Limerick, Limerick
Registry updated 2026-03-25
NCT05866757
Discontinuation Study
Trial Treatment · University College Cork
Cork University Hospital, Cork
Registry updated 2026-03-04
NCT06237803
European Myeloma Network (EMN) Sample Project
Research · European Myeloma Network B.V.
Beaumont Hospital, Dublin, Hematology Department, Galway
Registry updated 2025-12-03

All Multiple myeloma trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error